Pharmaceutical company Sanofi will collaborate with
clinical-stage messenger RNA therapeutics company to develop a novel mRNA
vaccine for COVID-19. This will be Sanofi's second collaboration in the effort
to develop a novel COVID-19 vaccine candidate. Their vaccine expertise from
external research networks will assist in advancing vaccine candidates for
potential further development. Translate Bio is producing multiple mRNA
constructs and will use their mRNA platform to discover, design and manufacture
a number of SARS-CoV-2 vaccine candidates. | https://bit.ly/2X5fsA3
"Great ideas, research and innovation can come from anyone – so often the best ideas do not have a voice. IdeaSpies provides a platform for people to share ideas that create a better world"
IdeaSpies
Jonathan Chrimes